Rethinking Drug Discovery

Sygnature scientists discuss and share their thoughts about drug discovery, laboratory practice and how to beat some of the world’s worst illnesses.

We have also launched our own webinar series, check it out.

Clear search
MORE...

Latest News

View All

First patients dosed in Phase 1a clinical…

Sygnature Discovery Appoints Industry Leaders To Board…

Sygnature Discovery invests £3.75M in Compound Management…

Sygnature Discovery collaborates with Axol Bioscience to…